Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.
about
P1343
The H19 non-coding RNA is essential for human tumor growthHepatitis B virus polymerase blocks pattern recognition receptor signaling via interaction with DDX3: implications for immune evasionAkt augments the oncogenic potential of the HBx protein of hepatitis B virus by phosphorylationInhibition of human hepatitis B virus replication by AT-61, a phenylpropenamide derivative, alone and in combination with (-)beta-L-2',3'-dideoxy-3'-thiacytidineViral and cellular determinants involved in hepadnaviral entryPseudomonas exotoxin antisense RNA selectively kills hepatitis B virus infected cellsFine mapping of pre-S sequence requirements for hepatitis B virus large envelope protein-mediated receptor interactionHepatitis Bx antigen stimulates expression of a novel cellular gene, URG4, that promotes hepatocellular growth and survivalHigh level expression of apoptosis inhibitor in hepatoma cell line expressing Hepatitis B virus.Advances and Challenges in Studying Hepatitis B Virus In VitroImmune-mediated Liver Injury in Hepatitis B Virus InfectionHepatitis B precore protein: pathogenic potential and therapeutic promiseHepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseasesHost cellular microRNA involvement in the control of hepatitis B virus gene expression and replicationCD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytesStealth and cunning: hepatitis B and hepatitis C viruses.Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells.Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agentsA Substituted Tetrahydro-Tetrazolo-Pyrimidine Is a Specific and Novel Inhibitor of Hepatitis B Virus Surface Antigen SecretionSuppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cellsCell therapy for the diseased liver: from stem cell biology to novel models for hepatotropic human pathogensCombination of small interfering RNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cellsApproved Antiviral Drugs over the Past 50 YearsCell Culture Models for the Investigation of Hepatitis B and D Virus InfectionMolecular biology of hepatitis B virus infectionTGF-β triggers HBV cccDNA degradation through AID-dependent deaminationThe Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic VirusesInhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analoguesThe polymerase L528M mutation cooperates with nucleotide binding-site mutations, increasing hepatitis B virus replication and drug resistanceInhibitory effects of acyclic nucleoside phosphonates on human hepatitis B virus and duck hepatitis B virus infections in tissue cultureMetabolic studies on BMS-200475, a new antiviral compound active against hepatitis B virusInhibition of episomal hepatitis B virus DNA in vitro by 2,4-diamino-7- (2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-pyrrolo[2,3-d]pyrimidineIdentification of BMS-200475 as a potent and selective inhibitor of hepatitis B virusInhibition of hepatitis B virus by a novel L-nucleoside, 2'-fluoro-5-methyl-beta-L-arabinofuranosyl uracil(-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine (524W91) inhibits hepatitis B virus replication in primary human hepatocytesStable Human Hepatoma Cell Lines for Efficient Regulated Expression of Nucleoside/Nucleotide Analog Resistant and Vaccine Escape Hepatitis B Virus Variants and Woolly Monkey Hepatitis B VirusDNA Polymerase κ Is a Key Cellular Factor for the Formation of Covalently Closed Circular DNA of Hepatitis B VirusHepatitis B virus molecular biology and pathogenesisAnti-HBV efficacy of combined siRNAs targeting viral gene and heat shock cognate 70.Interplay between the Hepatitis B Virus and Innate Immunity: From an Understanding to the Development of Therapeutic Concepts.
P2860
Q21144433-66639A7B-346F-4E6D-B1DD-34F853C62D87Q24293039-B712B124-275C-427B-9ABC-BDD7B33A985AQ24304579-D4F76442-F5E6-4E28-AF31-C61B97B32684Q24519050-428C3437-7461-4073-AD44-68AB6C5EA8C7Q24563902-46EA4163-4955-41A5-B21B-9AAD71007FE4Q24648726-27190458-2649-4A46-9B9F-3AADE1D41648Q24656570-877F37C8-AC53-4BF1-807A-7F5BDAA92EC8Q24682883-A3C13158-88C6-4594-B56D-ACAAF4821AB8Q24810149-137C3331-02BE-4195-A69D-F7BAD8A65AE8Q26771134-CCF867AB-70C7-4796-933D-014C37840D31Q26786772-0E549160-FF5A-498B-9C5D-A2E14C34B9ACQ26824158-4972F060-8E19-4E62-AF39-A6E5E7DE63FCQ27024630-E6A66F2D-936F-4F2B-89F3-1BC9562EFFD6Q27027473-8D9B0DD1-CFD2-4D60-94A3-B1A612B0B7F8Q27341786-E3B16657-40D8-4DAB-BDA6-28B6C8A2D9BCQ27470232-B7D6D272-975B-4BCF-B084-E0025DF74210Q27472707-55DFC66C-0A23-4CE5-BBF5-EA1153EC88F1Q27478192-98AF7093-BD66-4B7F-BB90-1F30556087D1Q27484471-30FBA298-160A-4D75-940D-F3205F33B532Q27486067-82FFB0B1-B54C-4AB0-B7CD-C222C8A74C70Q27487009-C80DDCFE-D956-4AAC-87DD-BA7944D27A02Q27489094-729B6014-E85F-4D6B-BDAB-6E5BE0B50DC3Q27755387-A00EC6D3-F145-4472-8017-739ED2C8C0ECQ28068209-4FD9EFFF-D084-4978-ABF0-A070127588F6Q28083478-BB922EFF-D118-4EF0-A77D-5505EA421025Q28119132-C67F70DA-7ED5-4BEF-A3D7-6BB8934257B1Q28271798-55B16748-1D2A-409D-9CFA-A9EC9273BEF8Q28321734-C882417D-400B-493D-A1AF-81062285395BQ28350136-5E43A83B-9123-45EB-99C1-0A120831278CQ28368243-9EE9AD6B-18D0-44AF-BA50-D5AB35C0E7B3Q28369473-1B1235BF-03D9-4EA1-9F73-409DA05C317CQ28378787-D29BB834-59CF-430A-8D13-425412B93EDEQ28379014-1F7E9DC2-4F41-43AC-B7B0-14050495ABD7Q28379171-76CB85A3-14BA-45AC-BE40-4F6151174A9AQ28379181-DFC4BE2F-3BDF-4C50-AC7F-15CB53B33F08Q28551711-10BF5208-2F1C-4105-9C85-AE404E63A2C3Q28552967-9C4099D0-D7AD-4366-97CC-426F2B5052DAQ28818406-58C993C4-8EA6-4A05-9378-56E5AA25AABAQ30531035-603994DA-D4EA-4E15-905F-BEBF1CCFADEAQ30854409-381E7B57-DFAC-4EFE-BDF9-DA757A08BBE5
P2860
Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.
description
1987 nî lūn-bûn
@nan
1987 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
name
Production of hepatitis B viru ...... cloned hepatitis B virus DNA.
@ast
Production of hepatitis B viru ...... cloned hepatitis B virus DNA.
@en
Production of hepatitis B viru ...... cloned hepatitis B virus DNA.
@nl
type
label
Production of hepatitis B viru ...... cloned hepatitis B virus DNA.
@ast
Production of hepatitis B viru ...... cloned hepatitis B virus DNA.
@en
Production of hepatitis B viru ...... cloned hepatitis B virus DNA.
@nl
prefLabel
Production of hepatitis B viru ...... cloned hepatitis B virus DNA.
@ast
Production of hepatitis B viru ...... cloned hepatitis B virus DNA.
@en
Production of hepatitis B viru ...... cloned hepatitis B virus DNA.
@nl
P2093
P2860
P356
P1476
Production of hepatitis B viru ...... cloned hepatitis B virus DNA.
@en
P2093
P2860
P304
P356
10.1073/PNAS.84.4.1005
P407
P4510
P577
1987-02-01T00:00:00Z